Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1670
-
Total 13F shares, excl. options
-
1.04B
-
Shares change
-
+6.16M
-
Total reported value, excl. options
-
$80.1B
-
Value change
-
+$434M
-
Put/Call ratio
-
0.78
-
Number of buys
-
709
-
Number of sells
-
-828
-
Price
-
$77.07
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2023
1,885 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q2 2023.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,670 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.04B shares
of 1.24B outstanding shares and own 83.72% of the company stock.
Largest 10 shareholders include BlackRock Inc. (126M shares), VANGUARD GROUP INC (113M shares), Capital World Investors (80.9M shares), STATE STREET CORP (59.3M shares), Capital Research Global Investors (57.9M shares), Dodge & Cox (34M shares), GEODE CAPITAL MANAGEMENT, LLC (24.2M shares), FMR LLC (20.1M shares), Bank of New York Mellon Corp (17.5M shares), and MORGAN STANLEY (16.8M shares).
This table shows the top 1670 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.